150 filings
Page 7 of 8
10-K/A
sx3x0bg
30 Apr 19
Annual report (amended)
4:59pm
8-K
xoa 6lvz7n25v0i84
12 Apr 19
Axonics® Appoints Nancy L. Snyderman, M.D. and Jane E. Kiernan
4:22pm
8-K
i2phnpuer2qbe
5 Mar 19
Axonics® Announces Fourth Quarter and Full Year 2018 Financial Results and Operational Update
4:05pm
8-K
r9mt2c5o88q0uu
5 Mar 19
Axonics® Appoints Michael H. Carrel to its Board of Directors
1:39pm
10-K
rpbnvrwk
5 Mar 19
Annual report
12:00am
10-Q
3oiminhe3em8njknmf
11 Dec 18
Quarterly report
4:31pm
8-K
hk53kgsu7xak9ofv eyd
11 Dec 18
Axonics® Announces Third Quarter 2018 Financial Results and Operational Update
4:06pm
CT ORDER
pplslud7 omoztf5egpt
6 Nov 18
Confidential treatment order
12:00am
S-8
nqkrb w9sx1
5 Nov 18
Registration of securities for employees
4:16pm
8-K
gs91 vay9ga6tcaza1
5 Nov 18
Axonics Modulation Technologies, Inc. Announces Pricing of
3:31pm
424B4
a28nyirj4jnky
1 Nov 18
Prospectus supplement with pricing info
12:00am
EFFECT
1uyn3qw ppugnggt9e
31 Oct 18
Notice of effectiveness
12:15am
S-1MEF
8mvx4h7y
30 Oct 18
Registration of additional securities for an S-1
8:25pm
CERT
4yudc5it zovx79yqp
29 Oct 18
Certification of approval for exchange listing
11:46am
CORRESP
mxln7ydpkch2
26 Oct 18
Correspondence with SEC
12:00am
CORRESP
94od3fy7a jxdyzw
26 Oct 18
Correspondence with SEC
12:00am
8-A12B
p9l8h6e
25 Oct 18
Registration of securities on exchange
5:01pm
S-1/A
u31e9g i8rd
22 Oct 18
IPO registration (amended)
6:10am
CORRESP
jnii8bq063 s6141
22 Oct 18
Correspondence with SEC
12:00am